Literature DB >> 9446709

Growth hormone secretagogues: focus on the growth hormone-releasing peptides.

V Locatelli1, A Torsello.   

Abstract

This review systematically analyses recent knowledge of the biology of the growth hormone-releasing peptides. Many years before native GHRH had been isolated and sequenced, the synthesis of an enkephalin analog, devoid of any opioid activity but capable of specifically releasing GH from in vitro pituitaries, prompted the design of a number of structurally interrelated GHRPs with improved GH-releasing activity. Nowadays, GHRPs are the most effective GH-secretagogues known and could be used profitably in humans with GH hyposecretory disturbances to promote a pattern of GH secretion that mimics physiology in a better way than the exogenously administered GH. Copyright 1997 The Italian Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9446709     DOI: 10.1006/phrs.1997.0253

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  3 in total

Review 1.  Ghrelin in gastroenteric pathophysiology.

Authors:  V Locatelli; E Bresciani; I Bulgarelli; D Rapetti; A Torsello; G Rindi; V Sibilia; C Netti
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

Review 2.  Current and potential roles of ghrelin in clinical practice.

Authors:  G Angelidis; V Valotassiou; P Georgoulias
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

Review 3.  Therapeutic potential of ghrelin in the treatment of heart failure.

Authors:  Noritoshi Nagaya; Kenji Kangawa
Journal:  Drugs       Date:  2006       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.